What is the appropriate assessment and management for a 17-year-old female presenting with mood instability, intense anger, substance use, and self‑cutting?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Assessment and Management of a 17-Year-Old Female with Mood Instability, Anger, Substance Use, and Self-Cutting

This adolescent requires immediate mental health professional evaluation during the office visit, with strong consideration for psychiatric hospitalization given the combination of self-harm behavior, substance use, low impulse control (anger), and mood instability—all of which place her at high risk for suicide. 1

Immediate Risk Assessment

Critical Questions to Ask

You must directly assess suicide risk at the initial encounter. Ask these specific questions 2, 3:

  • "Did you ever feel so upset that you wished you were not alive or wanted to die?"
  • "Did you ever try to kill yourself?"
  • "Did you think about or try to commit suicide?"
  • "Did you do anything to get ready to kill yourself?"
  • "Did you think what you did would kill you?"

High-Risk Indicators Present in This Patient

This patient demonstrates multiple high-risk features that mandate urgent psychiatric evaluation 1:

  • Active self-harm behavior (cutting) within the past year
  • Substance use disorder - a major risk multiplier
  • Mood instability and intense anger - suggesting possible bipolar disorder, major depression, or borderline personality features
  • Low impulse control - evidenced by anger outbursts and substance use
  • Adolescent female - at elevated risk for repeated self-harm

The combination of impulsivity, profoundly dysphoric mood, substance use, and self-harm behavior places her in the high-risk category requiring immediate intervention, not delayed outpatient referral 1.

Immediate Safety Interventions

Environmental Controls (Implement Today)

Restrict access to means of self-harm immediately 2:

  • Remove all firearms from the home
  • Lock up all medications (prescription and over-the-counter)
  • Remove pesticides, toxic substances, and sharp objects
  • Advise family to monitor access to high places

Contact and Monitoring

Establish regular contact with the patient through telephone, home visits, or brief clinic visits 2. This is a recommended intervention for persons with acts of self-harm in the last year and should continue throughout treatment.

Disposition Decision Algorithm

Hospitalization Criteria (Choose Psychiatric Hospitalization If):

  • High degree of intent to self-harm or suicide
  • Evidence of serious depression, bipolar disorder, or psychosis
  • Active substance use disorder (present in this case)
  • Low impulse control (present - anger outbursts)
  • Family unwilling to commit to intensive monitoring and counseling
  • Previous suicide attempts
  • Current agitation or severe hopelessness

Although no controlled studies prove hospitalization saves lives, it is the safest course of action for high-risk adolescents, providing a protected environment for complete psychiatric evaluation and treatment initiation 1.

Outpatient Management (Only If ALL of These Are Present):

  • Responsive and supportive family
  • Little likelihood of acting on self-harm impulses
  • Someone available 24/7 who can take action if deterioration occurs
  • No current suicidal intent or plan
  • Willingness to engage in intensive outpatient treatment

This patient does NOT meet criteria for outpatient-only management given substance use, impulsivity, and self-harm behavior.

Comprehensive Assessment Components

Psychiatric Diagnostic Evaluation

Assess for these specific conditions that commonly drive self-harm and mood instability 3, 4:

Primary mood disorders:

  • Major depressive disorder with or without psychotic features
  • Bipolar disorder (especially mixed states or rapid cycling)
  • Persistent irritability with mood shifts

Personality features:

  • Borderline personality disorder traits (unstable mood, impulsivity, repeated self-harm, unstable relationships)
  • Other Cluster B personality features

Trauma history:

  • Physical or sexual abuse
  • Interpersonal violence
  • Recent significant losses

Substance use specifics:

  • Type(s) of substances used
  • Frequency and quantity
  • Intoxication/withdrawal patterns
  • Relationship between substance use and self-harm episodes

Functional Assessment

  • Interpersonal relationship problems (current conflicts, recent losses)
  • School performance and attendance
  • Social isolation vs. peer support
  • Family psychopathology (especially suicide, bipolar disorder, substance abuse)
  • Cognitive distortions, particularly hopelessness

Treatment Framework

Psychotherapeutic Interventions

Dialectical Behavior Therapy for Adolescents (DBT-A) is the most evidence-based intervention for reducing self-harm repetition in adolescents 4. However, it requires:

  • Intensive commitment (prolonged therapy)
  • Adequate motivation
  • Family involvement capacity

If DBT-A is not feasible, implement a modified harm-reduction approach 5:

  • Structured behavioral agreements between patient, family, and clinical team
  • Environmental controls (means restriction)
  • Tangible reward systems for transparency and reduced severity
  • Focus on stabilizing wound severity rather than immediate cessation
  • Bridge to more intensive therapy as motivation improves

Problem-solving therapy should be considered as it has evidence for persons with self-harm 2.

Substance Use Treatment

Do not treat substance use and psychiatric disorders sequentially—integrate treatment 6. The substance use disorder must be addressed simultaneously with mood symptoms because:

  • Untreated substance use increases relapse rates
  • Mood symptoms may persist despite substance cessation
  • Substance use elevates suicide risk

Consider family-based interventions (multidimensional family therapy, family behavior therapy) which show efficacy for adolescent substance use with comorbid psychopathology 7, 6.

Pharmacotherapy Considerations

Vigorous treatment of the underlying psychiatric disorder is critical for reducing suicide risk 1. However:

  • Diagnosis must be clarified first (depression vs. bipolar disorder vs. borderline features)
  • If depression is diagnosed, antidepressant medication may be indicated, but requires close monitoring with frequent appointments
  • Educate family about warning signs requiring immediate contact
  • The benefits of antidepressants generally outweigh risks when appropriately monitored 1
  • Avoid medications that could be used for overdose—prescribe small quantities

Family and Social Support

Mobilize social support from informal and formal community resources 2. This is a recommended intervention for persons with self-harm.

Psychoeducation for family members should be routinely offered 2. Family must understand:

  • Warning signs of deterioration
  • When to seek emergency care
  • How to maintain environmental safety
  • The chronic nature of recovery

Follow-Up and Monitoring

Maintain contact even after psychiatric referral to enhance continuity and treatment adherence 1. Collaborative care between primary care and mental health providers reduces depressive symptoms more effectively than referral alone.

Regular reassessment is required because:

  • Suicide risk fluctuates
  • Lack of current suicidal ideation after an attempt may be misleading if underlying factors haven't changed
  • Adolescents may minimize symptoms or have hidden agendas

Critical Pitfalls to Avoid

  1. Do not rely on "no-harm contracts"—they are not proven effective in preventing suicidal behavior, though refusal to agree is an ominous sign 1

  2. Do not assume low risk based on low lethality of cutting method—adolescents often overestimate lethality and may escalate methods 1

  3. Do not hospitalize in general medical units solely to prevent self-harm—if imminent risk exists, refer to mental health services or mobilize family/community monitoring 2

  4. Do not treat substance use first and defer psychiatric treatment—integrated treatment is essential 6

  5. Do not discharge without ensuring means restriction and establishing a clear follow-up plan with identified responsible adults 2, 1

References

6
Research

Management of the adolescent with substance use disorders and comorbid psychopathology.

Child and adolescent psychiatric clinics of North America, 2010

7
Guideline

narrative review: revised principles and practice recommendations for adolescent substance use treatment and policy.

Journal of the American Academy of Child and Adolescent Psychiatry, 2025

Related Questions

What diagnosis and treatment are indicated for frequent intense crying, rapid overwhelm, sudden anger outbursts, frequent tantrums, and marked mood swings in the setting of ongoing family stress?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
In a male patient who is not a daily alcohol consumer but drank continuously for three days and then stopped, is he at risk for alcohol withdrawal?
What is the target LDL‑cholesterol level for a 47‑year‑old woman without comorbidities?
What is the appropriate analgesic management and potential viva questions for a 45‑year‑old adult with chronic hepatitis C (Child‑Pugh class A/B) presenting with flank pain and preserved liver and renal function?
In a patient who experienced mild itching of the hands and feet during iron sucrose infusion and, 24 hours later, presents with hemolysis, sub‑KDIGO acute kidney injury, proteinuria, and hematuria, how supportive is this of a complement‑mediated disorder such as atypical hemolytic‑uremic syndrome?
How long should a patient on nightly Topamax (topiramate) for migraine prophylaxis remain on treatment?
Why is high-flow nasal cannula (HFNC) so effective in bronchiolitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.